Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPV plus bivalent OPV versus bivalent OPV alone for polio immunogenicity in malnourished and normally nourished infants
ACTRN12612000259842Phase 4Not yet recruiting
- Sponsor
- World Health Organization
- Start
- Apr 2012
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of trivalent inactivated polio vaccine and bivalent oral poliovirus vaccine in poliomyelitis (4 arms), sponsored by World Health Organization. Primary endpoint: Seropositivity and mean geometric titer change in chronically malnourished infants. Planned start Apr 2012; status: not yet recruiting.
02
Drugs
trivalent inactivated polio vaccinebivalent oral poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on ACTRN12612000259842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000259842.